AMGNQ3 20261/4Estimate vs Actual
Earnings per Share
$6.45
+ 11.4% vs Estimate
Surprise as recorded in the analysis; the estimate itself is not on the calendar.
Amgen Q3 2026 · Story
Read the quarter card by card, ready to share.
AMGNQ3 20261/4AMGNQ3 20262/4Guidance
Full-Year Revenue
- Company Guidance
- 38.9 – 39.7 billion
- Market Estimate
- 38.9 billion
1.0% Above Estimate ▲
Full-Year Adjusted EPS
- Company Guidance
- 22.9 – 23.7 $
- Market Estimate
- 23.02 $
1.2% Above Estimate ▲
Full-Year GAAP EPS
- Company Guidance
- 18.34 – 19.28 $
Raised 14.4% ▲
AMGNQ3 20263/4In 30 Seconds
Revenue of $10.37B was 2.9% above estimates, and adjusted EPS of $6.45 beat by 11.4%.
- Full-year adjusted EPS guidance moved to $22.90–23.70; the midpoint is only 1.2% above market expectations.
- Shares were down 1.6% after hours following the call; for a stock already above analyst targets, the guidance raise offered limited upside.
First point of the analysis's “In 30 Seconds”.
Full AnalysisAMGNQ3 20264/4Score
74
ViewBUY
Not Investment Advice